Evidence map›Paper›PMID 42110716›Full record

ArticleFrontiers in human neuroscience2026

Long-term use of tDCS-clinical and ethical considerations.

Elodie Malbois, Samia Hurst, Raffaele Rodogno, Adrian G Guggisberg

Abstract read
In one paragraph

Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elodie MalboisInstitute for Ethics, History, and the Humanities, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Samia HurstInstitute for Ethics, History, and the Humanities, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Raffaele RodognoPhilosophy Department, University of Lausanne, Lausanne, Switzerland.
Adrian G GuggisbergDepartment of Clinical Neurosciences, Division of Neurorehabilitation, University Hospitals of Geneva, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique that delivers weak electrical currents to targeted brain regions in order to modulate neural activity and potentially enhance cognitive and motor functions. Clinical studies have reported benefits for conditions such as depression, stroke, and Parkinson's disease, typically with only minor and transient side effects. While short-term safety is relatively well established, the long-term effects require more systematic data and therefore require caution. At the same time, tDCS is increasingly being used at home without supervision for extended periods, as devices can be purchased online without prescription or even self-assembled. This situation highlights the need for appropriate safeguards to protect unsupervised users and to ensure that research into supervised long-term use is conducted under ethically acceptable conditions. In this paper, we specifically assess the risks that may arise from prolonged and unsupervised application of tDCS and propose measures that should be implemented by researchers, regulators, and commercial stakeholders involved in the distribution of tDCS devices.

Indexed as

citizen sciencemateriovigilanceresearch ethicssafetytranscranial brain stimulation

Identifiers

PMID42110716
PMCPMC13153068

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.